Dr. Susanne Baumeister shares the exciting advancements and the benefits of attending the CRI Immunotherapy Patient Summit in Boston, hosted at Dana-Farber Cancer Institute. #CRIsummit #Immunotherapy Susanne Baumeister, M.D., is a pediatric hematologist-oncologist in Boston, Massachusetts, affiliated with Boston Children’s Hospital and Dana-Farber Cancer Institute, and holds a faculty appointment at Harvard Medical School. She specializes in childhood blood cancers. The 2019 CRI Immunotherapy Summit in Boston was held at Dana-Farber Cancer Institute on July 27, 2019. Cancer Research Institute Immunotherapy Patient Summits are free half-day Saturday events that provide a forum for patients, caregivers, and advocates to meet together along with scientific and healthcare experts to learn more about how new breakthroughs in immunotherapy are changing standards of care for all cancers. Register at https://www.cancerresearch.org/summit Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization that is dedicated to harnessing our immune system's power to control and potentially cure all cancers. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field's leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. Our Mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. https://www.cancerresearch.org Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.